Delivery Order SPE2DB22D2006-SPE2DB25FW1FR

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product, with a ceiling value of $1,939.02 and a period of performance through May 21, 2025. The contract is a firm fixed price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,105.10 for the supply of DEXAMETHASONE 2 MG TABLET 100S. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $1,059.05 and a period of performance through May 30, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $1,208.84 and an ultimate completion date of January 31, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXAMETHASONE 4 MG TABLET 100S. The contract has a ceiling value of $1,011.00 and is a firm fixed price award from the Defense Logistics Agency, a defense agency. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
This federal contract award is a delivery order for $1,249.83 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product DEXAMETH SODIUM PHOSP, with a performance period through May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of 4560373921 - Dexamethasone 20 mg/5 ml vial, 5 ml, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $5,751.75 and a completion date of March 27, 2023. This contract was awarded on an unrestricted, full and open competition basis, with no set-aside...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Dexamethasone 0.5 mg/5 ml Elixir, a pharmaceutical product, with a ceiling value of $1,792.29 and a period of performance through March 14, 2024. The contract is a firm fixed price arrangement...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW1FR
    Delivery Order

This is a $2,547.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a medication, with a performance period ending on May 29, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor with no major subcontractors noted.

Generated 8/31/25, 1:09 AM